I have never engaged in nonconsensual sexual activity with anyone,” said the best-selling author in response to allegations ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $91 which represents a slight increase of $1.06 or 1.18% from the prior close of $89.94. The stock opened at $90.59 and touched ...

There’s more than one ghost in the machine in,” Nnedi Okorafor’s new sci-fi-adjacent novel finely attuned to our age of AI ...

Aria Aber’s debut about an Afghan German party girl in Berlin shows that there are plenty of ways to tell an outsider’s story ...

The colorful picture book is helping parents of young children deal with the difficult journey that follows a breast cancer ...

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $89.88 which represents a slight increase of $0.74 or 0.83% from the prior close of $89.14. The stock opened at $90.19 and ...

The Vanishing', Season 2 of the Disney+ anthology adaptation, R.L. Stine's works come to life onscreen once again.

Seasoned advisory group including RNA, translation and commercialisation luminaries.

Velia Therapeutics has announced it is winding down its operations while staying loyal to the therapeutic potential of ...

The biotech industry is booming thanks to the rising demand for personalized medicine, investment in innovations, and ongoing ...